6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

1 Completed trials

2 Sponsors

11 Countries

Phase II

Phase II: 3

Oversight events:

5 temporary halts 2 urgent safety measures 1 unexpected event across 2 trials

View oversight register →

Sponsors using this IMP

Janssen - Cilag International 2 Biogen Idec Research Limited 1

All trials

3 total

A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised

2022-501644-15-00 Phase II 11 countries Biogen Idec Research Limited
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-6404… Halted

2023-505096-68-00 Phase II 5 countries Janssen - Cilag International
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study with a Long-Term Extension Treatment Period to Assess the … Ended

2022-501188-42-00 Phase II 5 countries Janssen - Cilag International

Showing 1–3 of 3 trials

← All drugs A–Z